Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.

Pan Y, Wang Y, Xiong Y, Li P, Yu C, Liu P

Open source

DOI
10.1002/hon.70234
Published
2026 Sep
Container
Hematological oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hon.70234,
  title = {Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.},
  author = {Pan Y and Wang Y and Xiong Y and Li P and Yu C and Liu P},
  year = {2026},
  journal = {Hematological oncology},
  doi = {10.1002/hon.70234},
  url = {https://doi.org/10.1002/hon.70234}
}

RIS

TY  - JOUR
TI  - Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.
AU  - Pan Y
AU  - Wang Y
AU  - Xiong Y
AU  - Li P
AU  - Yu C
AU  - Liu P
PY  - 2026
JO  - Hematological oncology
DO  - 10.1002/hon.70234
UR  - https://doi.org/10.1002/hon.70234
ER  - 

APA

Y, P., Y, W., Y, X., P, L., C, Y., & P, L. (2026). Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.. Hematological oncology. https://doi.org/10.1002/hon.70234

Source records